Clinical trial management platform combining eSource and EDC with remote monitoring
CRIO builds integrated eSource and EDC software for clinical trials, serving pharma sponsors, biotech firms, CROs, and research sites. The tech stack (Java, C++, PostgreSQL, Oracle, MySQL) reflects a mature, regulated-software architecture. Hiring is accelerating across engineering, support, and product, but the pain-point list reveals operational friction: complex release processes, delivery scaling challenges, and debt collection delays suggest internal process bottlenecks that outpace product velocity.
CRIO is a clinical research platform founded in 2015 and headquartered in Boston. The software consolidates electronic source data capture (eSource) and electronic data capture (EDC) into a single system, eliminating manual data re-entry across trial workflows. The platform serves three buyer segments: research sites use it as an enterprise trial-management tool; sponsors and CROs deploy it for centralized data monitoring and remote patient monitoring. The product includes patient scheduling, financial management, data validation, autofill, and built-in compliance (21 CFR 11, ICH-GCP, GDPR, HIPAA). CRIO employs 51–200 people and operates in the United States.
CRIO's backend runs Java and C++ with PostgreSQL, MySQL, and Oracle databases. Frontend uses HTML and CSS. Operational tools include Jira, Confluence, Slack, HubSpot, and NetSuite.
Boston, Massachusetts. CRIO was founded in 2015 and remains privately held with 51–200 employees.
Other companies in the same industry, closest in size